Patient‐Derived Tumor Organoids Combined with Function‐Associated ScRNA‐Seq for Dissecting the Local Immune Response of Lung CancerChang Liu, Peng Liu, Kaiyi Li et al.|Advanced Science|2024Cited by 24
Huge heterogeneity of patient characteristics, treatment patterns, hospital costs exists in non-small cell lung cancer surgeries among different centers of China: A study of 5060 patients based on the Chinese national NSCLC outcome registry.Jian Zhou, Jun Wang, Lin Xu et al.|Journal of Clinical Oncology|2016Cited by 0